Director's Dealing • Mar 26, 2025
Director's Dealing
Open in ViewerOpens in native device viewer
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the "Market Abuse Regulation") and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B.
| 1. | Details of the person discharging managerial responsibilities/person closely associated | March 26, 2025 | |||
|---|---|---|---|---|---|
| a) | Name | MANJIN ApS | |||
| 2. | Reason for the notification | ||||
| a) | Position/status | Manjin ApS is wholly owned by Morten Otto Alexander Sommer, who is a member of the Board of Directors. |
Contact information Investor relations |
||
| b) | Initial notification/ Amendment |
Initial notification | Tobias Bjorklund +45 3077 8682 |
||
| 3. | auction monitor | Details of the issuer, emission allowance market participant, auction platform, auctioneer or | [email protected] | ||
| a) | Name | Novozymes A/S | Anders Enevoldsen +45 5350 1453 |
||
| b) | LEI | 529900T6WNZXD2R3JW38 | [email protected] | ||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
[email protected] | |||
| a) | Description of the financial instrument, type of instrument |
B-Shares | |||
| Identification code | DK0060336014 | ||||
| b) | Nature of the transaction | Purchase of shares | |||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
| DKK 402.4146 | 1,000 shares | ||||
| d) | Aggregated information - Aggregated volume - Price |
Number of shares: 1,000 Average price, DKK: 402.4146 Transaction value, DKK: 402,414.60 |
|||
| e) | Date of transaction | March 25, 2025 | |||
| f) | Place of the transaction | XCSE |
Contact information
Katrine Spedtsberg Poulsen [email protected]
Novonesis is a global leading biosolutions company transforming the way we all produce, consume and live. In more than 30 industries our biosolutions are helping companies meet their business needs and the needs of our planet. Our 10,000 people worldwide work closely with our partners and customers to challenge conventional thinking and transform business with biology.
Novozymes A/S, part of Novonesis Group Krogshoejvej 36 2880 Bagsvaerd Denmark
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.